SGS invests €3.5m in its French bioanalytical site
SGS’s facility in Poitiers, France offers contract bioanalytical services for both small molecules and biologics. The services extend to include mass spectrometry, immunoassays, and cell-based assays.
The first phase of the project was completed in November of this year. It saw the addition of a 150 square meter immunoassay laboratory and the capacity to employ 20 analysts.
Now, the next phase will begin with a new 800 square meter building which will house a new laboratory and office space. The renovation of the existing laboratory on site will also occur at this time.
The €3.5m ($3.9m) expansion project will also see a new electronic laboratory notebook system introduced across the entire facility in addition to an upgraded site quality management system and sample automation capabilities.
Over the past two years, the company has increased its staff recruitment by more than 25% and will continue to recruit and accelerate employment through Q3 2019.
SGS has 18 laboratories all of which offer contract analytical and bioanalytical services. SGS also provides Phase I-IV clinical trial management, and data management and statistics services.
The site expansion follows an investment and expansion of services at SGS’ site at its Lincolnshire, IL, Geneva and Mississauga, Canada laboratories.
